128 related articles for article (PubMed ID: 11463904)
1. Biomedicine. Huntingtin--profit and loss.
Trottier Y; Mandel JL
Science; 2001 Jul; 293(5529):445-6. PubMed ID: 11463904
[No Abstract] [Full Text] [Related]
2. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
Zuccato C; Ciammola A; Rigamonti D; Leavitt BR; Goffredo D; Conti L; MacDonald ME; Friedlander RM; Silani V; Hayden MR; Timmusk T; Sipione S; Cattaneo E
Science; 2001 Jul; 293(5529):493-8. PubMed ID: 11408619
[TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration. Huntington's research points to possible new therapies.
Marx J
Science; 2005 Oct; 310(5745):43-5. PubMed ID: 16210515
[No Abstract] [Full Text] [Related]
4. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
5. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.
Xie Y; Hayden MR; Xu B
J Neurosci; 2010 Nov; 30(44):14708-18. PubMed ID: 21048129
[TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration. A glutamine-rich trail leads to transcription factors.
Freiman RN; Tjian R
Science; 2002 Jun; 296(5576):2149-50. PubMed ID: 12077389
[No Abstract] [Full Text] [Related]
7. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.
Lee CY; Cantle JP; Yang XW
FEBS J; 2013 Sep; 280(18):4382-94. PubMed ID: 23829302
[TBL] [Abstract][Full Text] [Related]
8. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
[TBL] [Abstract][Full Text] [Related]
9. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
Dunah AW; Jeong H; Griffin A; Kim YM; Standaert DG; Hersch SM; Mouradian MM; Young AB; Tanese N; Krainc D
Science; 2002 Jun; 296(5576):2238-43. PubMed ID: 11988536
[TBL] [Abstract][Full Text] [Related]
10. HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation.
Carroll JB; Deik A; Fossale E; Weston RM; Guide JR; Arjomand J; Kwak S; Clish CB; MacDonald ME
PLoS One; 2015; 10(8):e0134465. PubMed ID: 26295712
[TBL] [Abstract][Full Text] [Related]
11. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
Nucifora FC; Sasaki M; Peters MF; Huang H; Cooper JK; Yamada M; Takahashi H; Tsuji S; Troncoso J; Dawson VL; Dawson TM; Ross CA
Science; 2001 Mar; 291(5512):2423-8. PubMed ID: 11264541
[TBL] [Abstract][Full Text] [Related]
12. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
Zuccato C; Belyaev N; Conforti P; Ooi L; Tartari M; Papadimou E; MacDonald M; Fossale E; Zeitlin S; Buckley N; Cattaneo E
J Neurosci; 2007 Jun; 27(26):6972-83. PubMed ID: 17596446
[TBL] [Abstract][Full Text] [Related]
13. Hunting in the calm before the storm.
Bates G; Eberwine J
Nat Genet; 2000 Aug; 25(4):365-6. PubMed ID: 10932169
[No Abstract] [Full Text] [Related]
14. The enigma of Huntington's disease.
Cattaneo E; Rigamonti D; Zuccato C
Sci Am; 2002 Dec; 287(6):92-7. PubMed ID: 12469651
[No Abstract] [Full Text] [Related]
15. Modeling Huntington's disease in cells, flies, and mice.
Sipione S; Cattaneo E
Mol Neurobiol; 2001 Feb; 23(1):21-51. PubMed ID: 11642542
[TBL] [Abstract][Full Text] [Related]
16. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.
Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ
J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678
[TBL] [Abstract][Full Text] [Related]
17. Loss of normal huntingtin function: new developments in Huntington's disease research.
Cattaneo E; Rigamonti D; Goffredo D; Zuccato C; Squitieri F; Sipione S
Trends Neurosci; 2001 Mar; 24(3):182-8. PubMed ID: 11182459
[TBL] [Abstract][Full Text] [Related]
18. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice.
Reiner A; Del Mar N; Deng YP; Meade CA; Sun Z; Goldowitz D
J Comp Neurol; 2007 Dec; 505(6):603-29. PubMed ID: 17948889
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
Zuccato C; Tartari M; Crotti A; Goffredo D; Valenza M; Conti L; Cataudella T; Leavitt BR; Hayden MR; Timmusk T; Rigamonti D; Cattaneo E
Nat Genet; 2003 Sep; 35(1):76-83. PubMed ID: 12881722
[TBL] [Abstract][Full Text] [Related]
20. The selective vulnerability of nerve cells in Huntington's disease.
Sieradzan KA; Mann DM
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
